Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT01881282

A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids

Conditions: Hemorrhoids

Sex: All
Ages: 16 Years – 75 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 123
Sponsor: Xian-Janssen Pharmaceutical Ltd.

Location: Beijing Hospital Beijing

Summary

The purpose of this study is to compare the therapeutic effect and safety of compound carraghenates cream with Mayinglong musk hemorrhoid (swollen veins in the lower part of the rectum or anus) ointment in the treatment of hemorrhoids, especially regarding the relief of pain.

Eligibility Criteria

Inclusion Criteria: * Participants who agree to participate in the current study * Participants having painful hemorrhoids (swollen veins in the lower part of the rectum or anus \[external hemorrhoid, mixed hemorrhoid, etc.\]) * Participants who did not use other topical drugs to treat their hemorrhoids a day before the inclusion * Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period Exclusion Criteria: * Participants having other anorectal diseases , such as anal fistula , anal cleft , perianal abscess , and anorectal occupied lesions etc * Participants having hypersensitive predisposition or hypersensitive to any of components of the study drugs * Female participants under pregnancy or during breastfeeding period * Participants who fail to accept the scheduled visits or are lost to the visits * Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or mental disorders

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01881282). StuddyBuddy aggregates publicly available trial information.